This exploratory study investigated the wider glycaemic impact of participation in a clinical exercise trial involving a therapeutic switch to ultra-long acting insulin degludec as well as the introduction to, and ad-hoc education support with, an interstitial glucose monitoring system in individuals with T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.